scispace - formally typeset
V

Vahid Jalili

Researcher at Oregon Health & Science University

Publications -  6
Citations -  285

Vahid Jalili is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Deep learning & Transformation (function). The author has an hindex of 2, co-authored 6 publications receiving 99 citations. Previous affiliations of Vahid Jalili include Broad Institute.

Papers
More filters
Journal ArticleDOI

The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update.

TL;DR: Key advances in Galaxy's user interface include enhancements for analyzing large dataset collections as well as interactive tools for exploratory data analysis and support for federated identity and access management and increased ability to distribute analysis jobs to remote resources.
Journal ArticleDOI

Galaxy-ML: An accessible, reproducible, and scalable machine learning toolkit for biomedicine.

TL;DR: Galaxy-ML as discussed by the authors is a biomedical computational workbench used by tens of thousands of scientists across the world, with a suite of tools for all aspects of supervised machine learning for biomedical data analysis.
Posted ContentDOI

Accessible, Reproducible, and Scalable Machine Learning for Biomedicine

TL;DR: Galaxy-ML is a platform that enables scientists to perform end-to-end reproducible machine learning analyses at large scale using only a web browser.
Posted ContentDOI

Adding software to package management systems can increase their citation by 280

TL;DR: The results suggest that there is significant evidence that the scholarly papers’ citation count increases after their respective software was published to package management systems, and may motivate scientists to invest in disseminating their software via package management system.
Posted ContentDOI

Rescuing Biologically Relevant Consensus Regions Across Replicated Samples

TL;DR: MSPC as discussed by the authors exploits replicates to lower the threshold required to identify a binding site while keeping a low false positive rate, which can be extended to call consensus regions across any number of replicated samples, accounting for differences between biological and technical replicates.